Divi's Lab.

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE361B01024
NSEID: DIVISLAB
BSEID: 532488
View on NSE | View on BSE

INR

6,109.35

86.45 (1.44%)

BSENSE

Mar 25

BSE+NSE Vol: 16.57 k

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,109.35",
    "chg": 86.45,
    "chgp": "1.44%",
    "dir": 1,
    "prev_price": "6,022.90",
    "mcapval": "162,184.05 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "16.57 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-technicals-3910771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910771.png",
        "date": "2026-03-24 15:00:27",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.26% surge in open interest (OI) in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, raising questions about the directional bets underpinning this spike in OI."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-technicals-3910650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910650.png",
        "date": "2026-03-24 14:00:23",
        "description": "Divis Laboratories Ltd, a prominent large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite the stock’s underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-notable-surge-in-derivatives-open-interest-amid-bearish-momentum-3910114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3910114.png",
        "date": "2026-03-24 11:00:05",
        "description": "Divis Laboratories Ltd, a large-cap heavyweight in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.08% surge in open interest (OI) in its derivatives segment, signalling a shift in market sentiment. Despite the stock trading below all major moving averages and a modest decline of 0.41% on the day, the spike in OI alongside rising volumes suggests increased investor participation and evolving directional bets."
      },
      {
        "title": "Divis Laboratories Ltd Surges 3.14% to Day's High of Rs 6158.95 — Outperforms Sector by 1.31 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-30-surge-on-20-mar-2026-3903228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_priceRelatedfactors_3903228.png",
        "date": "2026-03-20 13:15:51",
        "description": "The Sensex advanced 0.91% on 20 Mar 2026, yet Divis Laboratories Ltd outpaced the broader market with a 3.14% gain, reaching an intraday peak of Rs 6158.95. This 1.31-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a stock-specific strength rather than a general market uplift."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3898448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3898448.png",
        "date": "2026-03-18 10:10:49",
        "description": "Divis Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Divis Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-faces-bearish-momentum-amid-technical-downgrade-3892657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_technicaldot_3892657.png",
        "date": "2026-03-16 08:01:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, underscored by weakening moving averages and bearish momentum oscillators."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-13-mar-2026-3889974",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_priceRelatedfactors_3889974.png",
        "date": "2026-03-13 19:01:08",
        "description": "Divis Laboratories Ltd experienced a notable intraday decline on 13 Mar 2026, touching a low of Rs 6,051.8, reflecting a 3.58% drop from previous levels. The stock underperformed its sector and broader market indices amid widespread selling pressure, continuing a three-day downward trend."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3877819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3877819.png",
        "date": "2026-03-07 10:10:38",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Divis Laboratories Gains 1.92%: 3 Key Technical and Market Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-192-3-key-technical-and-market-factors-driving-the-week-3862608",
        "imagepath": "",
        "date": "2026-02-28 16:05:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Stock opened at Rs.6,294.70 with marginal gains despite Sensex rally</p>\n                    <p><strong>24 Feb:</strong> Price dipped 0.63% amid broader market weakness</p>\n                    <p><strong>25 Feb:</strong> Bearish technical shift noted; stock rebounded 2.29%</p>\n                    <p><strong>26 Feb:</strong> Sharp open interest surge and 1.13% price gain</p>\n                    <p><strong>27 Feb:</strong> Week closed at Rs.6,412.70, down 0.89% on weak market day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,291.95</di..."
      }
    ],
    "total": 597,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act 1961 for FY2022-23.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Mar-2026",
      "details": "Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "14-Feb-2026",
      "details": "Submission of transcript of Earnings Conference Call held on February 11 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals

2026-03-24 15:00:27

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.26% surge in open interest (OI) in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, raising questions about the directional bets underpinning this spike in OI.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Technicals

2026-03-24 14:00:23

Divis Laboratories Ltd, a prominent large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite the stock’s underperformance relative to its sector and benchmark indices.

Read full news article

Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Bearish Momentum

2026-03-24 11:00:05

Divis Laboratories Ltd, a large-cap heavyweight in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.08% surge in open interest (OI) in its derivatives segment, signalling a shift in market sentiment. Despite the stock trading below all major moving averages and a modest decline of 0.41% on the day, the spike in OI alongside rising volumes suggests increased investor participation and evolving directional bets.

Read full news article

Divis Laboratories Ltd Surges 3.14% to Day's High of Rs 6158.95 — Outperforms Sector by 1.31 Percentage Points

2026-03-20 13:15:51

The Sensex advanced 0.91% on 20 Mar 2026, yet Divis Laboratories Ltd outpaced the broader market with a 3.14% gain, reaching an intraday peak of Rs 6158.95. This 1.31-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a stock-specific strength rather than a general market uplift.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-03-18 10:10:49

Divis Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Divis Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-16 08:01:12

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, underscored by weakening moving averages and bearish momentum oscillators.

Read full news article

Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026

2026-03-13 19:01:08

Divis Laboratories Ltd experienced a notable intraday decline on 13 Mar 2026, touching a low of Rs 6,051.8, reflecting a 3.58% drop from previous levels. The stock underperformed its sector and broader market indices amid widespread selling pressure, continuing a three-day downward trend.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-03-07 10:10:38

Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook.